The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Drugs & Medical Devices ReNu MoistureLoc Research Center

Litigation Proliferates, 10.07

in this section: FDA ReNu Recall | W & L Press Release | FDA: Failure to Report, 11.06 | B&L Responds: ReNu FDA Letter 11.06 | FDA Warning | Litigation Proliferates, 10.07 | FDA Supports Withdrawal | FDA Public Health Notice | B&L Sales Fall | Bausch & Lomb Press Release | MultiPlus Recall, 3/07 | ReNu lawsuit


Bookmark This Page Print This Page Email This Page

Breaking News on ReNu Contact Lens Solution Litigation: 573 Lawsuits

October 29, 2007--BREAKING NEWS ON RENU LITIGATION: Makers of ReNu With MoistureLoc, Bausch & Lomb, Inc., has been slapped with 573 product liability lawsuits related to the defective contact lens solution, according to the Rochester Business Journal.

Of 344 ReNu claims filed in state courts, 308 cases have been consolidated in Supreme Court in New York City.

Last year, the Food and Drug Administration sent a warning letter to Bausch & Lomb for its "failure to establish and maintain procedures for the control of storage areas and stock rooms for product to prevent mix-ups, damage, deterioration, contamination, or other adverse effects" related to its production of ReNu solution in its Greenville, SC facility.

On August, 23, 2006, a US research report revealed that one-third of patients with a serious eye infection associated with the ReNu with MoistureLoc product had such severe infections that they had or will need a corneal transplant. Weitz & Luxenberg has spearheaded litigation related to the dangerous contact-lens solution, filing its first of several corneal transplant cases with the State Supreme Court of New York on May 5, 2006, court index # 106201/06.

If you have developed an severe eye infection resulting in vision loss after using ReNu contact lens solution, you may have a lawsuit claim against the manufacturer, Bausch & Lomb. To inquire about your possible ReNu lawsuit, fill out the form below for a free case evaluation. We will be in touch shortly.


Click To Talk To Us Online

Please complete the following questionnaire:

How long have you worn contact lenses?
How long have you been using ReNu with MoistureLoc contact lens solution?
Have you developed: fungal eye infection
any loss of vision
Were you using ReNu with MoistureLoc in the month prior to your eye infection?Yes
No
Have you sought treatment from a physician for your symptoms?Yes
No
Have you had a corneal transplant?Yes
No
Have you been told by a Doctor that you may need a corneal transplant?Yes
No
If yes to any of the above, please describe:
Additional Comments/Questions
Name
Email
Phone Number


see also:

FDA ReNu Recall FDA ReNu Recall - How does the ReNu Recall Affect You?
ReNu Recall - Bausch & Lomb Removes MoisureLoc from Shelves

W & L Press Release Weitz & Luxenberg Press Release: ReNu MoistureLoc Lawsuit Filed
Weitz & Luxenberg Files ReNu Lawsuit Against Bausch & Lomb

News & Warnings ReNu Lawsuit - Bausch & Lomb’s Contact Lens Solution News & Warnings
Keep up to date with ReNu Brand contact lens solution News & Warnings

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims